Medicure (TSE:MPH) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Medicure Inc. has completed the acquisition of intellectual property from CanAm Bioresearch, securing new chemical entities that could revolutionize disease treatment pending further studies and regulatory approval. The deal includes initial cash payment and milestone payments, plus a share of future net proceeds relating to the assets, indicating a strong potential for future revenue growth.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.